Yep, the $10m in fy21 is not just chips. Pretty hard to put a number on it but could we expect say 3/4 of the Labcon sales to be chips? If so, that's still approx 700,000 chips per month. Then add other oems into the equation and we should be up around the 1m mark I reckon.. Big job to scale up but we have the funds to do it now so very happy to hold and see how this plays out.. I'm expecting $15m in total revenue for fy21.. That should give us a mc of around $100m..
- Forums
- ASX - By Stock
- Ann: Annual Report to shareholders
Yep, the $10m in fy21 is not just chips. Pretty hard to put a...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.737M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BCT (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online